CoChat

A Review of Standards and Statistics Used to Describe Blood Glucose Monitor Performance

Open access
Krouwer, Jan S., Cembrowski, George S. · 2010 · Journal of Diabetes Science and Technology
Cited by 94

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Glucose performance is reviewed in the context of total error, which includes error from all sources, not just analytical. Many standards require less than 100% of results to be within specific tolerance limits. Analytical error represents the difference between tested glucose and reference method glucose. Medical errors include analytical errors whose magnitude is great enough to likely result in patient harm. The 95% requirements of International Organization for Standardization 15197 and others make little sense, as up to 5% of results can be medically unacceptable. The current American Diabetes Association standard lacks a specification for user error. Error grids can meaningfully specify allowable glucose error. Infrequently, glucose meters do not provide a glucose result; such an occurrence can be devastating when associated with a life-threatening event. Nonreporting failures are ignored by standards. Estimates of analytical error can be classified into the four following categories: imprecision, random patient interferences, protocol-independent bias, and protocol-dependent bias. Methods to estimate total error are parametric, nonparametric, modeling, or direct. The Westgard method underestimates total error by failing to account for random patient interferences. Lawton's method is a more complete model. Bland-Altman, mountain plots, and error grids are direct methods and are easier to use as they do not require modeling. Three types of protocols can be used to estimate glucose errors: method comparison, special studies and risk management, and monitoring performance of meters in the field. Current standards for glucose meter performance are inadequate. The level of performance required in regulatory standards should be based on clinical needs but can only deal with currently achievable performance. Clinical standards state what is needed, whether it can be achieved or not. Rational regulatory decisions about glucose monitors should be based on robust statistical analyses of performance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/193229681000400110

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 32

  1. 10.1515/CCLM.2006.152 · DOI
  2. ADA 1987 American Diabetes Association, 1987, Diabetes Care., 10, 93
  3. 2003, In vitro diagnostic test systems—requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus
  4. CLSI/NCCLS, 2002, Point-of-care blood glucose testing in acute and chronic care facilities approved guideline
  5. The six SIGMA handbook, revised and expanded. Pyzdek T, editor. McGraw-Hill; 2003. p 641–3.
  6. Alto WA, 2002, J Am Board Fam Pract., 15, 1
  7. 10.2337/diacare.10.5.622 · DOI · Paper page
  8. 10.1002/9780470316771 · DOI · Paper page
  9. 10.1093/clinchem/37.1.26 · DOI
  10. 10.1515/CCLM.2008.129 · doi:10.1515/cclm.2008.129
  11. 10.1373/clinchem.2007.094466 · DOI · Paper page
  12. Krouwer JS., 1992, Arch Pathol Lab Med., 116, 726
  13. 10.1093/clinchem/37.5.656 · DOI
  14. 10.1093/clinchem/41.10.1414 · DOI · Paper page
  15. 10.1093/clinchem/47.2.209 · DOI · Paper page
  16. Krouwer JS., 2001, Chem., 47, 1329
  17. Boyd JC, 2001, Clin Chem., 47, 1330, 10.1093/clinchem/47.7.1330 · doi:10.1093/clinchem/47.7.1330
  18. 10.1093/clinchem/48.3.436 · DOI · Paper page
  19. 10.1080/00401706.1979.10489809 · DOI
  20. Krouwer JS, 1995, Eur J Clin Chem Clin Biochem., 33, 525
  21. Monti KL., 1995, Am Stat., 49, 342
  22. CLSI/NCCLS, 2003, Estimation of total analytical error for clinical laboratory methods; approved guideline
  23. CLSI/NCCLS, 2009, How to construct and interpret an error grid for diagnostic assays EP27 proposed guideline
  24. CLSI/NCCLS, 2004, Evaluation of precision performance of quantitative measurement methods approved guideline
  25. CLSI/NCCLS, 2003, Evaluation of the linearity of quantitative measurement procedures: a statistical approach approved guideline
  26. CLSI/NCCLS, 2005, Interference testing in clinical chemistry approved guideline
  27. CLSI/NCCLS, 2002, Method comparison and bias estimation using patient samples; approved guideline
  28. CLSI/NCCLS, 2009, Evaluation of stability of in vitro diagnostic method products. Approved guideline
  29. 10.1177/014107689909200306 · DOI
  30. 10.1016/j.cca.2007.11.019 · DOI
  31. Box GE, 2005, Statistics for experimenters: design, innovation, and discovery
  32. CLSI/NCCLS, 2009, Approved guideline

Cited by

See all 94

Metadata

Authors
Krouwer, J. S., & Cembrowski, G. S.
Venue
Journal of Diabetes Science and Technology
Published
2010-01
Volume
4
Issue
1
Pages
75-83
ISSN
1932-2968 (ISSN-L)
OpenAlex
W2136364585
Cited by
94
References
7
Type
conference abstract
Language
en
Open access
bronze
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Review of Standards and Statistics Used to Describe Blood Glucose Monitor Performance. https://app.cochat.ai/papers/10.1177/193229681000400110
The paper
Krouwer, J. S., & Cembrowski, G. S. (2010). A Review of Standards and Statistics Used to Describe Blood Glucose Monitor Performance. Journal of Diabetes Science and Technology. https://doi.org/10.1177/193229681000400110

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.